» Authors » Anne-Lise Kamper

Anne-Lise Kamper

Explore the profile of Anne-Lise Kamper including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 76
Citations 1096
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Mannheimer E, Buus Jorgensen M, Hommel K, Kamper A, Jepsen R, Rasmussen K, et al.
Eur J Public Health . 2025 Jan; PMID: 39844623
Chronic kidney disease (CKD) affects 10-15% globally and is a marked independent risk factor for cardiovascular disease. Prevalence estimations are essential for public health planning and implementation of CKD treatment...
2.
Ballegaard E, Grove E, Kamper A, Feldt-Rasmussen B, Gislason G, Torp-Pedersen C, et al.
Clin J Am Soc Nephrol . 2024 Jul; 19(10):1263-1274. PMID: 39024026
No abstract available.
3.
Hansen N, Kamper A, Rix M, Feldt-Rasmussen B, Berg P, Astrup A, et al.
Nutrients . 2024 Jul; 16(13). PMID: 38999786
The New Nordic Renal Diet (NNRD) is a whole-food approach, tailored to meet recommended guidelines in patients with moderate chronic kidney disease (stage 3b-4). The NNRD improved various metabolic and...
4.
Ballegaard E, Carlson N, Buus Jorgensen M, Sorensen I, Trankjaer H, Almarsdottir A, et al.
Clin Kidney J . 2024 Jul; 17(7):sfae158. PMID: 38979108
Background: Although cardiovascular morbidity and mortality are substantial in patients with chronic kidney disease (CKD), guideline-directed treatment of cardiovascular risk factors remains a challenge. Methods: Observational, cross-sectional study including patients...
5.
Christensen J, Landler N, Olsen F, Sorensen I, Bjergfelt S, Ballegaard E, et al.
Int J Cardiovasc Imaging . 2024 Apr; 40(6):1221-1233. PMID: 38687429
Purpose: We investigated the associations between cardiac parameters and aetiologies of CKD in an exploratory study. Methods: The study population consisted of 883 participants, 174 controls and 709 patients with...
6.
Ballegaard E, Olesen J, Kamper A, Feldt-Rasmussen B, Gislason G, Torp-Pedersen C, et al.
Res Pract Thromb Haemost . 2024 Mar; 8(2):102350. PMID: 38481950
Background: The net benefit of oral anticoagulation (OAC) with vitamin K antagonists or direct oral anticoagulants in patients with advanced chronic kidney disease and atrial fibrillation remains uncertain. Objectives: We...
7.
Ballegaard E, Lindhard K, Lindhardt M, Peters C, Thomsen Nielsen F, Tietze I, et al.
BMJ Open . 2024 Feb; 14(2):e081961. PMID: 38413147
Introduction: Atrial fibrillation is highly prevalent in patients on chronic dialysis. It is unclear whether anticoagulant therapy for stroke prevention is beneficial in these patients. Vitamin K-antagonists (VKA) remain the...
8.
Binding C, Blanche P, Lip G, Kamper A, Lee C, Staerk L, et al.
Eur Heart J Cardiovasc Pharmacother . 2024 Feb; 10(3):210-218. PMID: 38402466
Background And Aims: Patients with severely reduced kidney function have been excluded from randomized controlled trials and data on the safety and efficacy of direct oral anticoagulants (DOACs) according to...
9.
Hansen N, Kamper A, Rix M, Feldt-Rasmussen B, Sorensen M, Berg P, et al.
Eur J Clin Nutr . 2024 Feb; 78(6):544-547. PMID: 38383708
The New Nordic Renal Diet (NNRD) is a meal pattern reduced in phosphorus, protein, and sodium for patients with moderate chronic kidney disease. The NNRD showed improvements in metabolic, and...
10.
Hansen N, Kamper A, Rix M, Feldt-Rasmussen B, Leipziger J, Sorensen M, et al.
Am J Clin Nutr . 2023 Aug; 118(5):1042-1054. PMID: 37598748
Background: Chronic kidney disease (CKD) leads to an accumulation of waste products and causes adverse cardiometabolic effects. Objectives: We investigated the health effects of the New Nordic Renal Diet (NNRD),...